SecBot SecBot
Insider Cluster (2 insiders) ·Filed Sep 15, 2026

RVMD

Revolution Medicines, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $1.4M total
Actionable Insight • Neutral

The insider selling is routine and non-informative, CFO sales are tied to option exercises, and the director's sale is trivial. No actionable signal for traders. Monitor for any upcoming clinical data readouts or regulatory catalysts that could move the stock, but this filing does not change the fundamental outlook.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$195.92
T+0 close · Sep 15, 2026 · via day close
Latest settled
−1.23%
T+20 · $193.52 · next T+60 in 23d
Vs SPY
−3.29%
α at T+20
Latest observation
−4.92%
T+41 · FF3 residual α
  1. T+0 · Sep 16 $195.92entry
  2. T+1 · 2mo ago +0.52%α −0.61% · $196.94
  3. T+5 · 8w ago −2.64%α −4.47% · $190.74
  4. T+20 · 5w ago −1.23%α −3.29% · $193.52
  5. T+43 · todayOpen
  6. T+60 · in 23d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at Revolution Medicines sold shares in a cluster totaling ~$1.37M in open-market sales, with additional derivative exercises and same-day sales by the CFO and a director. The sales are modest relative to the $43.9B market cap (~0.003%), making them routine and non-informative. The CFO's sales coincide with option exercises, suggesting tax-related or liquidity-driven transactions rather than a bearish signal. The director's single small sale is immaterial. No buying activity is present, and the cluster lacks the materiality or conviction to warrant a directional read.

Key Financial Metrics

Direction
selling
Total Value
$1.4M
Insiders
2

Key Facts

  • Two insiders sold shares: CFO Stephen Michael Kelsey sold ~$18.7M in open-market sales (across multiple trades on Sep 11) and exercised options; Director Lorence H. Kim sold 706 shares for ~$146K on Sep 8.
  • Total open-market sales in the cluster: ~$1.37M (Kelsey's sales are part of a larger 7-day pattern but the cluster window captures only a subset).
  • Sales represent ~0.003% of RVMD's $43.9B market cap, well below the 0.1% threshold for materiality.
  • CFO's sales coincide with option exercises at strike prices of $40.74 and $42.45, indicating a cashless exercise-and-sell pattern typical of tax withholding or liquidity needs.
  • No insider purchases in the cluster; net direction is selling.

Financial Impact

Total open-market sales of ~$1.37M, or ~0.003% of market cap, immaterial.

dilution

Risk Factors

  • Insider selling could be misinterpreted as bearish by retail traders despite being routine.
  • No buying activity to offset the selling, but the magnitude is too small to be meaningful.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (28 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RVMD-1789539457323

US Market Status

Market Closed · Opens Wed (9h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 16, 2026